• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

Professional Introduction to 4-Chloro-8-methoxyquinoline (CAS No. 16778-21-5)

4-Chloro-8-methoxyquinoline, identified by the Chemical Abstracts Service Number (CAS No.) 16778-21-5, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinoline family, a class of nitrogen-containing aromatic organic compounds that are widely recognized for their diverse biological activities and therapeutic potential. The structural features of 4-Chloro-8-methoxyquinoline, particularly the presence of a chlorine substituent at the 4-position and a methoxy group at the 8-position of the quinoline core, contribute to its unique chemical properties and reactivity, making it a valuable scaffold for the development of novel bioactive molecules.

The quinoline scaffold has a long history in medicinal chemistry, with several well-known drugs derived from this structure, such as chloroquine and quinine, which have been used for decades to treat malaria and other infectious diseases. The introduction of electron-withdrawing and electron-donating groups at specific positions on the quinoline ring can modulate its pharmacological profile, leading to the discovery of new compounds with enhanced efficacy and reduced side effects. In recent years, 4-Chloro-8-methoxyquinoline has been studied extensively for its potential applications in various therapeutic areas, including anti-inflammatory, antimicrobial, and anticancer therapies.

One of the most compelling aspects of 4-Chloro-8-methoxyquinoline is its versatility as a chemical building block. The chlorine atom at the 4-position provides a reactive site for further functionalization through nucleophilic substitution reactions, allowing chemists to introduce additional substituents that can fine-tune the biological activity of the molecule. Similarly, the methoxy group at the 8-position can participate in various chemical transformations, such as etherification or oxidation reactions, enabling the synthesis of structurally diverse derivatives. These properties make 4-Chloro-8-methoxyquinoline an attractive candidate for drug discovery campaigns aimed at identifying novel therapeutic agents.

Recent research has highlighted the potential of 4-Chloro-8-methoxyquinoline as an intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are frequently dysregulated in cancer cells. Inhibiting specific kinases has emerged as a promising strategy for cancer therapy, and quinoline-based inhibitors have shown considerable promise in preclinical studies. Studies have demonstrated that derivatives of 4-Chloro-8-methoxyquinoline can selectively target certain kinases by interacting with their active sites or allosteric regions. This selectivity is critical for minimizing off-target effects and improving therapeutic outcomes.

Another area where 4-Chloro-8-methoxyquinoline has shown promise is in antimicrobial applications. Antibiotic resistance is a growing global health concern, and there is an urgent need for new antibiotics to combat resistant bacterial strains. Quinoline derivatives have demonstrated broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. The structural features of 4-Chloro-8-methoxyquinoline, including its ability to disrupt bacterial cell membranes or interfere with essential metabolic pathways, make it a potential candidate for developing novel antimicrobial agents.

The synthesis of 4-Chloro-8-methoxyquinoline typically involves multi-step organic reactions starting from readily available precursors such as 8-methoxypyridine or 2-chloropyridine. Advanced synthetic methodologies, including palladium-catalyzed cross-coupling reactions and transition-metal-mediated cyclizations, have been employed to construct the quinoline core efficiently. These synthetic strategies not only improve yield but also allow for greater control over regioselectivity and stereoselectivity, which are essential for producing compounds with optimal biological activity.

In addition to its pharmaceutical applications, 4-Chloro-8-methoxyquinoline has been explored in materials science and nanotechnology. Quinoline-based compounds can form coordination complexes with metal ions, leading to functional materials with applications in catalysis, luminescence, and molecular recognition. The ability to tune the electronic properties of these complexes by modifying substituents on the quinoline ring makes them valuable for developing advanced materials with tailored functionalities.

The pharmacokinetic properties of 4-Chloro-8-methoxyquinoline are also an important consideration in drug development. Studies have investigated its absorption, distribution, metabolism, excretion (ADME) profiles to understand how it behaves within the body after administration. These studies help in optimizing dosing regimens and predicting potential side effects. For instance, understanding how quickly the compound is metabolized by enzymes such as cytochrome P450 can provide insights into its bioavailability and half-life.

Future research directions involving 4-Chloro-8-methoxyquinoline may focus on exploring its role in precision medicine. By leveraging genomic data and computational modeling techniques, researchers can identify specific genetic markers that correlate with responses to quinoline derivatives like 4-Chloro-8-methoxyquinoline. This approach could lead to personalized treatment strategies where patients receive medications tailored to their individual genetic profiles.

The development of novel drug delivery systems is another area where 4-Chloro-8-methoxyquinoline could play a significant role. Nanotechnology-based delivery platforms have shown promise in enhancing drug solubility, improving targeted delivery to diseased tissues, and reducing systemic side effects. By incorporating 4-Chloro-8-methoxyquinoline into these systems, researchers aim to develop more effective therapies with improved patient compliance.

In conclusion,4-Chloro-8-methoxyquinoline (CAS No., 16778-21-5) is a multifaceted compound with broad applications across pharmaceuticals, materials science, and nanotechnology. Its unique structural features make it a valuable scaffold for developing novel bioactive molecules with potential therapeutic benefits in various diseases. Ongoing research continues to uncover new applications for this compound，underscoring its importance as both a chemical intermediate and a functional material.

• 4295-04-9(4-Chloro-6-methoxyquinoline)
• 16492-13-0(9-Chloro-2-methoxyacridine)
• 88914-97-0( )
• 25395-13-5(8-Quinolinol,5-chloro-, hydrochloride (1:1))
• 57334-36-8(4-Chloro-8-quinolinol)
• 99878-79-2(4-Chloro-7,8-dimethoxyquinoline)
• 86-38-4(6,9-dichloro-2-methoxy-acridine)
• 5428-11-5(Quinoline, 4-chloro-5,8-dimethoxy-)
• 89784-84-9(Acridine, 9-chloro-4,5-dimethoxy-)
• 130-16-5(Cloxiquine)